Lupus & antiphospholipid syndrome

LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis

LupusPublished Bioinformatic analysis with clinical validation study

Authors' conclusion

STAT1 is a key gene in the development of LN. In conclusion, lncRNA XIST, miR-381-3P, and STAT1 can be used as new molecular markers to assist in the diagnosis of LN

Study context

Population
Female patients with systemic lupus erythematosus (SLE) (validation cohort); Lupus nephritis (LN) gene expression microarrays from GEOfemale patients with SLE
Participants
37 patients
Outcome
Differentially expressed genes and diagnostic value of the lncRNA XIST/miR-381-3P/STAT1 axis in LN
Methodological detailsGEO microarray datasets GSE157293 and GSE112943, protein-protein interaction (PPI) network, lncRNA-miRNA-mRNA regulatory network prediction, dual luciferase, RT-qPCR, ROC analysis
  • GEO microarray datasets GSE157293 and GSE112943
  • PPI network
  • lncRNA-miRNA-mRNA regulatory network prediction
  • Dual luciferase
  • RT-qPCR
  • ROC analysis

Performance

As reported in the abstract

Differential genes screened in GSE157293

133

Differential genes screened in GSE112943

2869

Differentially co-expressed genes

26

Core genes screened (STAT1, OAS2, OAS3, IFI44, DDX60, IFI44L)

6

Original publication

LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis. Lupus. Published 9 August 2024. doi:10.1177/09612033241273072

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.